These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 9776208)

  • 1. Fibrinolysis and the plasma carboxypeptidase.
    Nesheim M
    Curr Opin Hematol; 1998 Sep; 5(5):309-13. PubMed ID: 9776208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteolytic activation of purified human procarboxypeptidase U.
    Schatteman KA; Goossens FJ; Scharpé SS; Hendriks DF
    Clin Chim Acta; 2000 Feb; 292(1-2):25-40. PubMed ID: 10686274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TAFI, or plasma procarboxypeptidase B, couples the coagulation and fibrinolytic cascades through the thrombin-thrombomodulin complex.
    Bajzar L; Morser J; Nesheim M
    J Biol Chem; 1996 Jul; 271(28):16603-8. PubMed ID: 8663147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of plasmin-mediated activation of plasma procarboxypeptidase B. Modulation by glycosaminoglycans.
    Mao SS; Cooper CM; Wood T; Shafer JA; Gardell SJ
    J Biol Chem; 1999 Dec; 274(49):35046-52. PubMed ID: 10574983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombin, thrombomodulin and TAFI in the molecular link between coagulation and fibrinolysis.
    Nesheim M; Wang W; Boffa M; Nagashima M; Morser J; Bajzar L
    Thromb Haemost; 1997 Jul; 78(1):386-91. PubMed ID: 9198184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombin-activatable fibrinolysis inhibitor antigen and TAFI activity in patients with APC resistance caused by factor V Leiden mutation.
    Antovic JP; Blombäck M
    Thromb Res; 2002 Apr; 106(1):59-62. PubMed ID: 12165290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A study of the mechanism of inhibition of fibrinolysis by activated thrombin-activable fibrinolysis inhibitor.
    Wang W; Boffa MB; Bajzar L; Walker JB; Nesheim ME
    J Biol Chem; 1998 Oct; 273(42):27176-81. PubMed ID: 9765237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carboxypeptidase U at the interface between coagulation and fibrinolysis.
    Schatteman K; Goossens F; Leurs J; Verkerk R; Scharpé S; Michiels JJ; Hendriks D
    Clin Appl Thromb Hemost; 2001 Apr; 7(2):93-101. PubMed ID: 11292199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombin activatable fibrinolysis inhibitor and an antifibrinolytic pathway.
    Bajzar L
    Arterioscler Thromb Vasc Biol; 2000 Dec; 20(12):2511-8. PubMed ID: 11116046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombin activatable fibrinolysis inhibitor (TAFI): a molecular link between coagulation and fibrinolysis.
    Miljić P; Heylen E; Willemse J; Djordjević V; Radojković D; Colović M; Elezović I; Hendriks D
    Srp Arh Celok Lek; 2010 Jan; 138 Suppl 1():74-8. PubMed ID: 20229688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assay of procarboxypeptidase U, a novel determinant of the fibrinolytic cascade, in human plasma.
    Schatteman KA; Goossens FJ; Scharpé SS; Neels HM; Hendriks DF
    Clin Chem; 1999 Jun; 45(6 Pt 1):807-13. PubMed ID: 10351989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombomodulin in human plasma contributes to inhibit fibrinolysis through acceleration of thrombin-dependent activation of plasma procarboxypeptidase B.
    Hosaka Y; Takahashi Y; Ishii H
    Thromb Haemost; 1998 Feb; 79(2):371-7. PubMed ID: 9493593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Regulatory mechanism of fibrinolysis system by thrombin activatable fibrinolysis inhibitor (TAFI)].
    Urano T
    Nihon Yakurigaku Zasshi; 2000 Nov; 116(5):298-303. PubMed ID: 11215380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombin-activatable fibrinolysis inhibitor.
    Marx PF
    Curr Med Chem; 2004 Sep; 11(17):2335-48. PubMed ID: 15379716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Thrombin activatable fibrinolysis inhibitor (TAFI) and its importance in the regulation of fibrinolysis].
    Stasko J; Hudecek J; Kubisz P
    Vnitr Lek; 2004 Jan; 50(1):36-44. PubMed ID: 15015228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma TAFI levels influence the clot lysis time in healthy individuals in the presence of an intact intrinsic pathway of coagulation.
    Mosnier LO; von dem Borne PA; Meijers JC; Bouma BN
    Thromb Haemost; 1998 Nov; 80(5):829-35. PubMed ID: 9843179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Curiouser and curiouser: recent advances in measurement of thrombin-activatable fibrinolysis inhibitor (TAFI) and in understanding its molecular genetics, gene regulation, and biological roles.
    Boffa MB; Koschinsky ML
    Clin Biochem; 2007 Apr; 40(7):431-42. PubMed ID: 17331488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myocardial infarction and the balance between fibrin deposition and removal.
    Nesheim M
    Ital Heart J; 2001 Sep; 2(9):641-5. PubMed ID: 11666089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombin and fibrinolysis.
    Nesheim M
    Chest; 2003 Sep; 124(3 Suppl):33S-9S. PubMed ID: 12970122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma carboxypeptidases as regulators of the plasminogen system.
    Redlitz A; Tan AK; Eaton DL; Plow EF
    J Clin Invest; 1995 Nov; 96(5):2534-8. PubMed ID: 7593646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.